NCT06942728 · NOT YET RECRUITING

Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment

This trial tests a home-based computerized brain training program called nLIFE EyeFitness — a tablet or PC software that exercises attention, memory, reaction time, and executive function — in adults 60 and older who have mild cognitive impairment and some degree of vision difficulty. It is a Phase N/A study, meaning it is a feasibility or exploratory investigation, not a pivotal efficacy trial. The goal is to see whether this kind of personalized digital cognitive training can support people at this early stage.

You may qualify if

  • Patients aged ≥ 60 years with a diagnosis of aMCI
  • Signing of informed consent

You're excluded if

  • Age \<60 years
  • History of dementia
  • Diabetes mellitus
  • Uncontrolled hypertension
  • Diagnosis of major depression
  • Glaucoma
  • Age-related macular degeneration
  • Media opacity and vitreoretinal pathologies that may preclude a correct evaluation
  • • Failure to obtain informed consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-04-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials